FIELD: medicine, virology. SUBSTANCE: the suggested preparation contains hyaluronic acid, trimecaine, glycerol and polyethylenoxide. Preparation is obtained either as a gel or an ointment. A kind of medicinal form depends upon molecular weight of polyethylenoxide used. EFFECT: increased therapeutic and antiherpetic activity, improved transdermal, wound-healing and antiviral actions. 1 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
HYALURONIC ACID-BASE PHARMACOLOGICAL AGENT SHOWING ANTIBACTERIAL, WOUND-HEALING AND ANTI-INFLAMMATORY EFFECT | 1999 |
|
RU2195262C2 |
ALPHA-2-INTERFERON-BASED ANTIVIRAL AGENT IN CREAM FORM | 1998 |
|
RU2159609C2 |
ANTIVIRAL AGENT | 1996 |
|
RU2123339C1 |
COMPLEX ANTIVIRAL MEDICATION FOR EXTERNAL APPLICATION IN TREATMENT OF HERPES VIRUS INFECTIONS | 2010 |
|
RU2438697C1 |
LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
AGENT "KOLLAGEL" FOR TREATMENT OF SUPPURATIVE-NECROTIC WOUNDS AND BURNS | 1997 |
|
RU2139044C1 |
PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
AGENT FOR EXTERNAL USE WITH ANTIVIRAL ACTION | 2021 |
|
RU2819719C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2351322C1 |
Authors
Dates
2002-01-27—Published
1999-11-24—Filed